ROCKVILLE, Md.--(BUSINESS WIRE)--Feb. 27, 2009--
Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company
will be webcasting its presentation at the Cowen & Co. 29th
Annual Health Care Conference scheduled for Tuesday, March 17, 2009 at
10:15 am Eastern. A member of the company’s senior management team will
provide a corporate overview, including a discussion of product
development programs, recent corporate activities and financial
performance.
A webcast of this presentation will be available both live and by
replay. To access either the live or archived webcast, please proceed to www.emergentbiosolutions.com,
and click on the “Investors” link the day of the presentation.
An archived replay of the webcast will be available 24 hours after the
live presentation.
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the
development, manufacture and commercialization of immune-related
biologic products, consisting of vaccines and therapeutics that assist
the body’s immune system to prevent or treat disease. Emergent’s
marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is
the only vaccine approved by the U.S. Food and Drug Administration for
the prevention of anthrax infection. Emergent’s development pipeline
includes programs focused on anthrax, botulism, typhoid, tuberculosis,
hepatitis B and chlamydia. Additional information may be found at www.emergentbiosolutions.com.
Source: Emergent BioSolutions Inc.
Emergent BioSolutions Inc.
Investors Contact:
Robert G.
Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media
Contact:
Tracey Schmitt
Director, Corporate Communications
301-795-1800
SchmittT@ebsi.com
